Skip to main content

Table 6 Median and range for EDSS by treatment with p-value and standardized effect size, d

From: Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

Measure Treatment
A: Placebo B: Melatonin p d
Median Range Median Range
Visual 1.0 0–4 1.5 0–4 0.056 0.539
Brainstem 1.0 0–2 1.0 0–2 0.288 0.292
Sensory 3.0 0–4 3.0 0–3 0.090 0.474
Pyramidal 2.0 0–3 2.0 0–3 0.386 0.238
Cerebellar 2.0 1–4 2.0 0–3 0.181 0.370
Cerebral 2.0 0–3 2.0 0–3 0.653 0.123
Bladder and Bowel 2.0 1–3 2.0 0–3 0.674 0.115
Ambulatory 1.0 0–9 1.0 0–9 1.00 0.000
EDSS 4.0 1.5–8 4.0 3–8 0.209 0.347